Product Acquisitions And Return Of Product Rights - Change in Consideration, Vibativ (Details) - USD ($) |
3 Months Ended | |
---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
Loss Contingency Accrual [Roll Forward] | ||
Change in fair value of contingent consideration included in operating expenses | $ (230,430) | $ (267,637) |
Product Assets And Global Rights - Vibativ | ||
Loss Contingency Accrual [Roll Forward] | ||
Beginning balance | 4,033,373 | |
Cash payment of royalty during the period | (394,426) | |
Change in fair value of contingent consideration included in operating expenses | 28,072 | |
Contingent consideration earned and accrued in operating expenses | 0 | |
Ending balance | $ 3,667,019 |